Digital Health Investors & VC Firms in United States

872 firms in this list, with a median first check of $500K. 249 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
ZÜ Zühlke Ventures PGSW2 people · Follows rounds	88🔒	Zurich	CH	Pre-Seed–Series A	$165K – $275K	+ Add to CRM
PR PreAngel Fund LWHLJZWH4 people	88🔒	Beijing	CN	Pre-Seed–Series A	$20K – $1M	+ Add to CRM
GR Gruppo Bertoldi GBGB2 people	88🔒	Trento	IT	Seed–Late Stage	—	+ Add to CRM
VE Vertex Ventures HC CBLHYLJS4 people	88🔒	Singapore	SG	Seed–Growth	$500K – $10M	+ Add to CRM
AD AddVentures by SCG SPCLPJRM6 people	88🔒	Bangkok	TH	Seed–Late Stage	$1.5M – $66M	+ Add to CRM
LY LYZZ Capital CTEZKLTY5 people	88🔒	Shanghai	CN	Seed–Series A	—	+ Add to CRM
RO Rosetta Capital Ltd. JHKMMFDL8 people	88🔒	Oxford	GB	Series A–Late Stage	—	+ Add to CRM
FU Future Positive Capital PR1 person · Follows rounds	88🔒	—	FR	Pre-Seed–Series A	—	+ Add to CRM
MA Maximus Ventures BCDAAACK15 people	88🔒	—		Seed–Series C	—	+ Add to CRM
FL Flintera SVNDRUAC4 people · Leads rounds	88🔒	—		Seed–Late Stage	$10M – $60M	+ Add to CRM
TR TransPacific Venture Partners MLPJ2 people	88🔒	Taipei City	TW	Seed–Series B	$500K – $3M	+ Add to CRM
IS Israel Innovation Authority HBSR2 people	88🔒	Jerusalem	IL	Pre-Seed–Growth	$140K – $5M	+ Add to CRM
NO North South Ventures ALDNITPK4 people	88🔒	Toronto	CA	Pre-Seed–Series B	—	+ Add to CRM
SE Seido Capital CPOBTRPE4 people · Leads rounds	88🔒	Brussels	BE	Pre-Seed–Late Stage	$270K – $2.7M	+ Add to CRM
10 10x Group FHJBRWAE6 people	88🔒	München	DE	Seed–Late Stage	—	+ Add to CRM
AD Addventure MMPT2 people	88🔒	Nicosia	CY	Seed–Series A	$1M – $10M	+ Add to CRM
DC DCI Partners Co. Ltd. LLHYWFHN4 people	88🔒	Tokyo	JP	Pre-Seed–Growth	$4.3M – $71M	+ Add to CRM
BO Boehringer Ingelheim Venture Fund JGAKDHDH7 people	88🔒	Ingelheim am Rhein	DE	Seed–Growth	$16.2M	+ Add to CRM
SB SBI Investment Korea Co. Ltd.	88🔒	Seoul	KR	Seed–Late Stage	$2.5M – $33M	+ Add to CRM
TH THENA Capital ERPSLTY6 people · Leads rounds	88🔒	—	GB	Pre-Seed–Series A	$6.3M	+ Add to CRM
AL Alesta Yatırım	88🔒	Istanbul	TR	Pre-Seed–Growth	$9K – $1M	+ Add to CRM
CE CentreStone Ventures ADJKME3 people	88🔒	Winnipeg	CA	Pre-Seed–Series A	$182.5K – $1.8M	+ Add to CRM
IN Indicator Capital DBFIGWMR6 people · Leads rounds	88🔒	São Paulo	BR	Pre-Seed–Series A	—	+ Add to CRM
KA Kalei Ventures JSLPTB3 people	88🔒	—	AR	Pre-Seed–Series A	$100K – $300K	+ Add to CRM

Zühlke Ventures

ZurichPre-Seed–Series A$165K – $275K

PGSW2 people

PreAngel Fund

BeijingPre-Seed–Series A$20K – $1M

LWHLJZWH4 people

Gruppo Bertoldi

TrentoSeed–Late Stage

GBGB2 people

Vertex Ventures HC

SingaporeSeed–Growth$500K – $10M

CBLHYLJS4 people

AddVentures by SCG

BangkokSeed–Late Stage$1.5M – $66M

SPCLPJRM6 people

LYZZ Capital

ShanghaiSeed–Series A

CTEZKLTY5 people

Rosetta Capital Ltd.

OxfordSeries A–Late Stage

JHKMMFDL8 people

Future Positive Capital

Pre-Seed–Series A

PR1 person

Maximus Ventures

Seed–Series C

BCDAAACK15 people

Flintera

Seed–Late Stage$10M – $60M

SVNDRUAC4 people

TransPacific Venture Partners

Taipei CitySeed–Series B$500K – $3M

MLPJ2 people

Israel Innovation Authority

JerusalemPre-Seed–Growth$140K – $5M

HBSR2 people

North South Ventures

TorontoPre-Seed–Series B

ALDNITPK4 people

Seido Capital

BrusselsPre-Seed–Late Stage$270K – $2.7M

CPOBTRPE4 people

10x Group

MünchenSeed–Late Stage

FHJBRWAE6 people

Addventure

NicosiaSeed–Series A$1M – $10M

MMPT2 people

DCI Partners Co. Ltd.

TokyoPre-Seed–Growth$4.3M – $71M

LLHYWFHN4 people

Boehringer Ingelheim Venture Fund

Ingelheim am RheinSeed–Growth$16.2M

JGAKDHDH7 people

SBI Investment Korea Co. Ltd.

SeoulSeed–Late Stage$2.5M – $33M

THENA Capital

Pre-Seed–Series A$6.3M

ERPSLTY6 people

Alesta Yatırım

IstanbulPre-Seed–Growth$9K – $1M

CentreStone Ventures

WinnipegPre-Seed–Series A$182.5K – $1.8M

ADJKME3 people

Indicator Capital

São PauloPre-Seed–Series A

DBFIGWMR6 people

Kalei Ventures

Pre-Seed–Series A$100K – $300K

JSLPTB3 people

Data sourced from public filings and firms' own websites — see our methodology.